A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)

Ryzhikov, A. B. ; Ryzhikov, Е. А. ; Bogryantseva, M. P. ; Usova, S. V. ; Danilenko, E. D. ; Nechaeva, E. A. ; Pyankov, O. V. ; Pyankova, O. G. ; Gudymo, A. S. ; Bodnev, S. A. ; Onkhonova, G. S. ; Sleptsova, E. S. ; Kuzubov, V. I. ; Ryndyuk, N. N. ; Ginko, Z. I. ; Petrov, V. N. ; Moiseeva, A. A. ; Torzhkova, P. Yu ; Pyankov, S. A. ; Tregubchak, T. V. ; Antonec, D. V. ; Gavrilova, E. V. ; Maksyutov, R. A.

Infekt͡s︡ii͡a︡ i immunitet, 2021-04, Vol.11 (2), p.283-296 [Periódico revisado por pares]

Sankt-Peterburg : NIIÈM imeni Pastera

Texto completo disponível